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 Glaucoma, the second leading cause of blindness in de-
veloped countries [1], is characterized by progressive damage
of the optic nerve associated with a selective loss of the reti-
nal ganglion cells [2]. The precise mechanisms involved in
glaucoma have yet to be determined, but it is widely accepted
that a better appreciation of the factors involved in ganglion
cell death is central to the future development of an overall
strategy for treatment [3,4].
Animal disease models have long been used as surrogates
for human diseases and have been informative. In vivo mod-
els with elevated intraocular pressure (IOP) have enabled,
apoptosis of retinal ganglion cells to be observed in rats [3]
and monkeys [4]. These models are probably good represen-
tations of the situation seen in glaucomatous patients [5]. In
such models, several studies looked at the mechanisms of pres-
sure-induced optic nerve damage [6], selective loss of gan-
glion cell function in rats with experimental glaucoma [7],
and the anatomy and pathophysiology of the optic nerve head
in glaucoma [8]. However, in vivo models may not represent
the only approach to study a complex problem in which mul-
tiple factors are likely involved.
Several other experimental models have been used to ini-
tiate and study ganglion cell death, including direct damage
to the rat optic nerve [3,9] and exposure to elevated concen-
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Purpose: Glaucoma is a progressive eye disease that leads to blindness due to loss of retinal ganglion cells (RGCs). There
are difficulties in using primary cultures of purified RGC to study this pathophysiology. RGC-5, a transformed not RGC
line, expresses several markers characteristic of the RGCs. The aim of this study was to generate a genome-wide gene
expression of RGC-5 following serum deprivation and to identify candidate genes that may be involved in the signal
transduction pathways.
Methods: Apoptosis in the transformed rat RGC-5 was induced by serum deprivation for 0, 8, 24, 48, and 96 h. Briefly,
400 ng of RNA from each sample was reverse transcribed and labeled with Cy3 dye. Fragmented fluorescent cRNA was
mixed with hybridization buffer and incubated at 60 °C for 16 h. Labeled cRNA was hybridized to Rat Genome Oligo-
nucleotide Arrays. These arrays contain 22,775 transcripts with one oligonucleotide per transcript (60-mer). Gene expres-
sion from scanned images was quantified and analyzed using ArrayVision software. Reproducibility among triplicate
arrays was determined by ANOVA statistical analysis. Significant differences in gene expression between apoptotic and
nonapoptotic cells were determined based on p-values.
Results: Of the 22,775 transcripts present on the arrays (Agilent rat genome, 60-mer), 713 (8 h), 1,967 (24 h), 1,011 (48
h), and 1,161 (96 h) were differentially expressed relative to the 0 h time point (p-values <0.05). Twenty-three transcripts
were common to 8, 24, 48, and 96 h and 130 transcripts were common to the 24, 48, and 96 h time points. The two most
highly upregulated genes were Fdft1 and Lgals3 (8 h), C3 and Fcgrt (24 h), C and Lcn2 (48 h), and Mgp and C3 (96 h). A
subset of the differentially expressed genes identified in microarray data (Ftl1, C3, C1s, Neu1, Polr2g, Acadm, Nupr1,
Gch, Dia1, DNase1, Tgfb2, and Cyr61) were validated using quantitative real time polymerase chain reaction (QRT-
PCR). Here we show that complement factor H (CFH), the major inhibitor of the alternative complement pathway is
downregulated in serum-deprived RGC-5. CFH protein was detected within RGC-5 cells as well as the rat retina with the
aid of immunocytochemistry and confocal microscopy.
Conclusions: This study was undertaken to generate a genome-wide gene expression profile of RGC-5 after serum dep-
rivation, and to identify candidate and novel genes that may be involved in the signal transduction pathways leading to
apoptosis. RGC-5 serum deprivation revealed up-and downregulation in gene expression profiles. The data gathered from
this study was the first report that the genes identified in microarray data and validated by real-time RT-PCR may play an
important role in RGC-5 cell death. Among the validated genes, C3 and C1s showed significant upregulation of the
complement component pathway. The results further indicate that components of the complement pathway are present in
neurons of the rat retina. The data indicated that complement factors are likely involved in the pathway leading to ganglion
cell death in the serum-deprivation paradigm, which may be similar to the mechanism of cell death in glaucoma.
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trations of glutamate or its analogues [10,11]. A reduction in
the level of neurotrophic factors [2,12] and the possible over-
exposure to glutamate [13,14] have received recent attention.
Both conditions have been shown to affect the survival of reti-
nal ganglion cells (RGCs), and therefore, are implicated in
the pathophysiology of RGC cell death in glaucoma. While
the relationship of excitotoxicity to glaucoma has been con-
troversial, Ullian et al. [15] recently confirmed the likelihood
of a connection between glaucoma and elevated levels of
glutamate in the retina [16].
In some cases, isolated as well as purified ganglion cells
have been used to explore the pathophysiology of cell death
[17,18]. However, the use of primary cells in culture may also
be problematic for larger scale studies because of the limited
lifespan of the culture, the potential contamination problems
[19,20], and the limited yields [21]. To overcome such prob-
lems, a permanently transformed RGC line (RGC-5) was re-
cently established [22,23]. RGC-5 cells have been shown to
have some [22], but not all [24], of the phenotypic properties
of RGCs. We have used the RGC-5 line to look for prospec-
tive factors that may be involved in retinal ganglion cell death.
Advances in genomics and microarray technology pro-
vide an excellent opportunity to examine global changes in
retinal gene expression profiles in diseases and models of dis-
eases [25,26]. DNA microarrays have been utilized in many
applications for identifying changes in gene expression pat-
terns including neurodegenerative diseases [27,28].
Microarrays have already been used to investigate human as-
trocytes cultured from glaucomatous and normal optic nerve
heads [29]. They have also been used to construct a custom
cDNA microarray of a human retina, [30] to evaluate gene
expression patterns in the rat nervous system, [31] and to iden-
tify patterns of retinal mRNA expression after experimental
elevation of IOP in a rat glaucoma model [32].
In this study, we used 60-mer oligonucleotide-based spot-
ted microarrays, which are known to have good sensitivity
under various hybridization conditions [33]. The sensitivity
of the 60-mer oligonucleotide microarrays is reported to be
about two to eight times, [33,34] better, when compared to the
25-mer arrays, partly due to the larger area available for hy-
bridization. Microarray experiments are now routinely used
to collect large-scale data over time which can facilitate the
quantitative analysis of genetic regulatory processes [35].
Maher and Hanneken [36] concluded that the RGC-5 line
is an excellent model for studying mechanisms of RGC death
in response to oxidative stress and for the identification of
neuroprotective compounds. We utilized the oligonucleotide-
60-mer microarrays to investigate the global pattern of gene
expression upon serum-deprived induction of RGC-5 cell death
and compared the results to those reported earlier for this model
[23]. The results presented in this paper were compared with
purified rat retinal ganglion cells (cDNA screening library)
[18] and with a recent microarray study of the rat retina in
which elevation of IOP was used to evaluate gene expression
[32].
METHODS
Cell culture:  Cultures of RGC-5 cells were maintained in
growth medium containing low-glucose Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum
(FCS), 100 U/ml penicillin, and 100 µg/ml streptomycin
(Sigma-Aldrich, St. Louis, MO) in a humidified atmosphere
of 95% air and 5% CO2 at 37 °C, as described by
Krishnamoorthy et al. [22,23]. The cells were subcultured
every 48 to 72 h with a doubling time of about 18-20 h. To
induce apoptosis, the growth medium was withdrawn (serum
starvation) and cells were maintained in DMEM for 0, 8, 24,
48, and 96 h. Total RNA was extracted from each time point
and maintained at -80 °C until used for analysis. The source
of RGC-5 cells was provided by Dr. Agarwal.
Preparation of DNA fragmentation:  Apoptotic cells typi-
cally produce a ladder of nucleotide fragments that can be
easily visualized by agarose gel electrophoresis. DNA frag-
mentation was isolated and carried out as previously described
by Fujikawa et al [37]. We adapted these procedures by ex-
tracting genomic DNA from apoptotic and nonapoptotic RGC-
5 samples by collecting both floating and attached cells using
centrifugation. These cells were harvested and rinsed with ice-
cold phosphate buffered saline (PBS). The pellets were solu-
bilized in 390 µl lysis buffer (30 µl of 10 mM Tris-HCl, pH
8.0); 60 µl of 100 mM sodium chloride, 150 µl of 25 mM
EDTA; (150 µl of 0.5% SDS) and 0.4 mg/ml proteinase K.
They were then incubated at 55 °C overnight in a rotor shaker.
Samples were extracted twice with phenol: chloroform (1:1)
and once with chloroform. DNA was precipitated using one
volume of 3 M sodium acetate, pH 5.2 and cold 100% etha-
nol, followed by washing with 70% ethanol. Pellets were dried
using a refrigerated Speed Vac concentrator (Savant, Pittsboro,
NC) and dissolved in 1X TE buffer. DNase-free RNase was
added to the samples to a final concentration of 100 µg/ml
and incubated at 37 °C for 3 h. The samples were incubated
for 30 min at 37 °C followed by 5 min at 65 °C. DNA was
subjected to electrophoresis in 2% agarose gel, and the bands
were visualized with the aid of ultraviolet (UV) irradiation
after ethidium bromide staining.
RNA extraction:  Total RNA was extracted from the RGC-
5 cells using spin columns (RNeasy; Qiagen, Valencia, CA),
followed by DNase treatment according to the manufacturer’s
instructions. The quantity and purity of total RNA for samples
were analyzed with spectrophotometry readings at 260/280
nm. The integrity of intact total RNA was verified with an
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto,
CA), and the RNA Integrity Numbers (RINs) for the samples
were obtained. For routine RNA quality control analysis,
Agilent’s 2100 bioanalyzer with an RNA 6000 Nano
LabChip® Kit (Agilent) was used. RNA samples were each
prepared to a concentration of 25 ng/µl in parallel to a 6000
RNA ladder (Ambion, Houston, TX). The range of 28S/18S
ribosomal RNA was typically 1.8-2.1.
cRNA preparation:  A total of 15 samples were used for
cDNA synthesis, three separate biological samples of total
RNA from RGC-5 for five time points. Equal quantities of
294total RNA from the samples were labeled using Agilent low
RNA input fluorescent linear amplification kit, and hybrid-
ized to three independent identical arrays of Agilent oligo-
nucleotide probe sequences. Briefly, total RNA (400 ng) was
reverse transcribed into cDNA, using Moloney murine leuke-
mia virus (MMLV) reverse transcriptase with oligo(dT) pro-
moter primer, and incubated at 40 °C for 2 h. Fluorescent
cRNAs were synthesized by in vitro transcription using T7
RNA polymerase and labeled with cyanine 3-labeled dCTP
(PerkinElmer, Boston MA). Labeled cRNAs were further pu-
rified using RNase mini purification columns (Qiagen) to re-
move unlabeled products. Fifteen picomoles of the
fluorescently labeled cRNAs were used for each of the
microarray hybridizations.
Microarray hybridization:  The hybridization solution was
prepared using the in situ hybridization kit plus (Agilent). The
Agilent 60-mer array (G4130B) contains 22,775 rat probe se-
quences which include 162 negative controls and 913 posi-
tive controls. Each array contains one probe sequence (60-
mer) per transcript spotted using a noncontact spotter onto
specially prepared glass slides. Hybridizations were performed
using the manufacturer’s oligo processing protocols (Agilent).
About 0.75 µg of labeled cRNA and 5 µl of 25X fragmenta-
tion buffer were incubated at 60 °C for 30 min. Hybridization
was carried out in 490 µl of a hybridization mixture at 60 ° for
17 h in Agilent’s microarray hybridization chambers accord-
ing to the Agilent protocol. The 15 microarrays slides repre-
senting 15 samples were washed for approximately 30 s each
in 6x SSPE, 0.005% sarcosine and 0.006x SSPE.
Digitization of images and statistical analysis:  The ar-
rays were scanned immediately after hybridization with a pixel
resolution of 10 µm using a laser Typhoon 9410 scanner (GE
HealthCare, Piscataway, NJ) that excites the Cy3 (green)
fluorophore at optimal wavelengths of 532. Arrays were
scanned at different photomultiplier tube (PMT) voltages (500-
700 PMT). PMT setting of 600 nm was found to be optimal
for signal detection analysis based on negative and positive
controls that were included in the array platforms. Images were
captured and saved by ImageQuant software v. 5.2 (GE
HeathCare, Piscataway, NJ). Images were then loaded into
ArrayVision v.8.0 software (Imaging Research Inc., Ontario,
Canada) to calculate the median intensities for each spot of
Cy3 fluorescent signals.
The net intensity of a spot (one gene) was calculated by
subtracting the median of the background intensities from the
median of the chip replicates spot intensities. These back-
ground-corrected intensities were then normalized by the me-
dian normalization method. The fold change values for the
differentially expressed genes were calculated from ratios of
intensities between the two time points designated as test
groups. The t-test p-values (in which two-sample unequal vari-
ances were used) were utilized to detect the significance of
differences between the two test groups. Log ratios of intensi-
ties for individual genes were determined for each test/con-
trol (serum-deprived/nondeprived) group, from which the
mean value of log ratios for each sample group was also ob-
tained.
Biological pathways analysis:  Differentially expressed
genes, which had RefSeq annotations were subsequently ana-
lyzed using PathwayAssist software (Iobion Informatics, LLC,
La Jolla, CA). We constructed tables showing gene associa-
tions with cellular processes, as well as figures showing the
association of altered genes with more complete gene-regula-
tory networks.
Real-time polymerase chain reaction:  Quantitative Real-
Time PCR values (Applied Biosystems; 7300 instrument) of
the differentially expressed genes detected in serum-deprived
(8, 24, 48, and 96 h) and nondeprived (zero time point) RGC-
5 cells were used to validate the microarray results. The primer
pairs for each cDNA were obtained from Applied Biosystems
demand-assay. Briefly, the sequences for each selected gene
from microarray results were used to conduct a BLASTN
search against Rattus norvegicus (rat) on the NCBI database.
The sequences of primers designed were selected to be within
the same region of the gene used to develop the microarray
sequence probes. Two micrograms of total RNA from deprived
and nondeprived samples were used to generate cDNA tem-
plates for RT-PCR. cDNA synthesis was performed using a
High-Capacity cDNA Archive Kit (Applied Biosystems). The
first strand cDNA products were further diluted 20-50 fold
and used as PCR templates. The TaqMan® Master Mix Re-
agent Kit (Applied Biosystems) was used to amplify and quan-
tify each transcript of interest in 40 µl reactions. To ensure
specific amplification, various negative controls in the PCR
reaction. Triplicate PCR reactions were performed in 96-well
plates for each gene in parallel with the 18S rRNA. The steps
involved in the reaction program included in the following:
the initial step of 2 min at 50 °C; denaturation at 95 °C for 10
min, followed by 40 thermal cycles of denaturation (15 s at 95
°C), and elongation (1 min at 60 °C). Quantitative values are
obtained from the cycle number (Ct value) using the
Biosystems analysis software. The threshold cycle (CT) val-
ues were averaged from the values obtained from each reac-
tion, and each gene was normalized to 18S rRNA level. Each
gene of interest and 18S rRNA were tested in triplicates to
determine the Ct-difference. These Ct values were averaged
and the difference between the 18S Ct (Avg) and the gene of
interest Ct (Avg) was calculated (Ct-diff). The fold change
was calculated by the 2-∆CT, where ∆∆CT=(CTapoptotic-
CTnon-apoptotic). CT apoptotic means the signal of an indi-
vidual gene expressed in time course samples (8, 24, 48, and
96 h), while CTnon-apoptotic means the signal of the same
gene expressed in 0 h. The relative expression of the gene of
interest was analyzed using the 2-∆∆CT method [38].
Confocal microscopy:  Whole eyes of adult Sprague-
Dawley rats were isolated, fixed in 4% paraformaldehyde,
embedded in paraffin, sectioned at a thickness of 5 µm, and
deparaffinized prior to immunocytochemical treatment. RGC-
5 cells were fixed in 4% paraformaldehyde and rinsed in PBS;
pH 7.4. The sections or cells were then immersed in a 0.1
Triton X-100 solution for 30 min and rinsed in PBS at least
three times for 5 min each. Samples were then treated with a
0.05 M solution of glycine for 15 min to eliminate free alde-
hydes. The sections and cells were subsequently incubated in
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295a blocking solution of 5% bovine serumm albumin (BSA),
and 10% normal serum of the host animal for the secondary
antibody was also in PBS for 15 min. This was followed by an
overnight incubation at 4 °C with primary antibodies for fac-
tor H (Santa Cruz Biotechnology, Santa Cruz, CA) diluted to
1 µg/ml in a solution of 1% BSA and 1% normal serum of
secondary antibody host animal in PBS. For controls, the pri-
mary antibody was omitted and replaced by goat IgG at the
same concentration as the primary antibody. After incubation,
the study samples were rinsed four times in PBS and incu-
bated with the secondary, antibody (goat) coupled to Alexa
green 488 (Molecular Probes, Inc) diluted 1:200 in buffer for
1 h at room temperature. The sections and cells were then
rinsed in PBS. To visualize the nuclei, we stained the sections
and cells with Hoechst nuclear stain (Hoechst number 33342
trihydrochloride trihydrate, Invitrogen) diluted according to
the manufacturer’s recommendation for 5-10 min at room tem-
perature in the dark. The sections and cells were again rinsed
in PBS and double distilled water, mounted with antifade
mounting media, and examined with a Zeiss LSM410 confo-
cal microscope (Carl Zeiss Microimaging, Inc., Thornwood,
NY) with a 40X water immersion objective (numerical aper-
ture 1.2). Samples were excited at 488 nm (for Alexa 488)
using an argon ion laser (Melles Girot/Omnichrome, Carlsbad,
CA) and fluorescence collected with a 510-525 nm emission
filter. Hoechst nuclear stain was excited at 364 nm with a UV
laser (Coherent Innova Technology, Santa Clara, CA), and fluo-
rescence emission was collected using a 400-440 nm emis-
sion filter.
RESULTS
Microarray gene expression:  Comprehensive gene expres-
sion profiles were examined to identify genes associated with
apoptosis and signaling transduction pathways in serum-de-
prived RGC-5 cells. DNA fragmentation was used to confirm
that the serum-deprived RGC-5 cells (0, 8, 24, 48, and 96 h)
were dying. The results showed that the level of DNA laddering
gradually increased with time in the serum-deprived condi-
tion (Figure 1). The data presented showed fragmentation of
DNA into different length pieces (180 bp). In addition, no DNA
fragmentation was observed in the control culture (0 h) com-
pared with the other serum-deprived cultures, thereby con-
firming that this sample can serve as a control sample. These
results indicated that the number of the dying cells in the se-
rum-deprived condition increased with time. It was noted that
there were scant levels of DNA fragmentation in the 8 h
samples. The graded accumulation of cell death in the serum-
deprived RGC-5 cells allowed us to analyze changes in gene
expression levels at these different time points.
Volcano plots were used to determine the most signifi-
cant altered expression of genes based on both traditional fold
changes and statistical p-values (Figure 2). This figure shows
the log2 fold change of normalized intensity versus their log10
p-values for 4 time points relative to the zero time point. These
data include 8 h versus 0 h (Figure 2A), 24 h versus 0 h (Fig-
ure 2B), 48 h versus 0 h (Figure 2C), and 96 h versus 0 h
(Figure 2D). Spots in the extreme upper left and right corners
of the volcano plots marked the largest, and most statistically
significant, changes in gene expression. For each gene present,
the volcano plot consisted of a plot containing log2 of the fold
change for two conditions on the x axis and the negative log10
of the p value on the y axis. The dots above the horizontal line
indicated the p-value of <0.05 for gene expression for both
annotated and nonannotated genes. For example, in 8 h versus
0 h samples, the log2 at a scale of 1 showed a 2 fold change on
the X axis, and -log10 at a scale of 1.3 on the Y axis equal to a
p-value of 0.05. Therefore, based on the fold change and p
value the horizontal line indicates the changes in gene expres-
sion values used in this study. This procedure was used to
identify changes in gene expression at all time points.
Identification of differentially expressed genes:  Of 22K
transcripts, 713 transcripts (8 h); 1,967 transcripts (24 h); 1011
transcripts (48 h), and 1,162 transcripts (96 h) were found to
be differentially expressed relative to the control (0 h) condi-
tion. From the differentially expressed data (Figure 2), we pre-
©2007 Molecular Vision Molecular Vision 2007; 13:293-308 <http://www.molvis.org/molvis/v13/a33/>
Figure 1. Apoptotic DNA fragmentation in serum-deprived retinal
ganglion cell-5 samples.  DNA was extracted and electrophoresed in
parallel on the same agarose gel with ethidium bromide staining.
Lane 2 (0 h), and lane 3 (8 h) show a lack of DNA fragmentation, but
lanes 4, 5, and 6 show a ladder of internucleosomal DNA fragments.
In dying cells, DNA is cleaved by an endonuclease that fragments
the chromatin into nucleosomal units, which are multiples of about
180-bp oligomer at about 200 bp. Molecular weight standards are
shown on lane one on the same gel.
296pared a list of the annotated (RefSeq accession numbers) and
nonannotated (EST accession numbers) transcripts. For the
annotated genes, there were 169 genes for 8 h/0 h, 418 genes
for 24 h/0 h, 217 genes for 48 h/0 h, and 153 genes for 96 h/0
h. Based on the p-value cutoff (<0.05), a list of 23 differen-
tially expressed transcripts whose expression was either up-
or downregulated were identified as common to all 4 time
points (8, 24, 48, and 96 h) as indicated in Table 1. Of these 23
transcripts (Table 1) there were 7 transcripts with RefSeq ac-
cession numbers (annotated) and 16 ESTs (nonannotated). In
this table there were a number of genes that were consistently
upregulated including DNnase I (NM_013097), rat cDNA
clone (AI071183), and normalized rat brain, transcribed locus
(AI229209). Of the 23 genes there were 10 genes that were
upregulated using the stringent criterion (p<0.05) for signifi-
cance. This stringency was used to minimize the prospect of
obtaining false positives.
The data was reexamined without the 8 h time point to
determine if there were significant changes subsequent to this
time point. Clearly at the 8 h time point there was scant DNA
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Figure 2. Volcano plot of normalized median intensities of retinal ganglion cells serum-deprived.  The Volcano plots show differentially
expressed genes at 8 h versus 0 h (A), 24 h versus 0 h (B), 48 h versus 0 h (C), and the 96 h versus 0 h (D) samples. The gene-specific F-test
(y-axis) denoting significance for each gene is represented as individual spot (Σ). The Volcano plots allowed the visualization of fold-change
and statistically significant p-values at the same time. Thus, the statistical significance of either large or small fold changes can be seen.
Volcano Plots show genes that have significantly different expression between two sample types based on both biological difference (absolute
log2 (estimated fold change) greater than some constant threshold) and statistical difference (-log10 (p value) greater than some constant
threshold). Volcano plots have a “V” shape appearance so there will usually be no genes with small biological effect (i.e., log (fold change)
close to 0) with high statistical significance.
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TABLE 1. DIFFERENTIALLY EXPRESSED GENES IN SERUM DEPRIVED AT 8, 24, 48, AND 96 H
List of differentially expressed genes whose expression values changes in serum-deprived RGC-5 cells at 8, 24, 48, and 96 h.
TABLE 2. DIFFERENTIALLY EXPRESSED GENES IN SERUM DEPRIVED AT 24, 48, AND 96 H
List of differentially expressed genes whose expression values changes in serum-deprived RGC-5 cells at 24, 48, and 96 h.
298fragmentation (Figure 1), and consequently, a limited number
of differentially expressed genes were observed at this time
point. This manipulation led to the identification of 130 tran-
scripts (39 RefSeq and 91 ESTs transcripts) that were com-
monly detected in the 24, 48, and 96 h time points (Table 2).
The data indicated that a large number of known and unknown
genes could be identified. Those genes, which have RefSeq
accession numbers, were the primary focus for this study be-
cause they represented a database of genes that have been docu-
mented at a higher level of certainty than those found in other
experimental gene collections such as UniGene. The RefSeq
annotated genes were used for further analysis and validation.
Identification of cell death-related genes:  To identify
genes that are associated with cell death in the RGC-5 cells,
we searched accession numbers in the NCBI database. The
number of differentially expressed genes previously reported
to be involved in neuronal cell death varied among the time
courses as follows: 14 genes (8 h), 19 genes (24 h), 13 genes
(48 h), and 23 genes (96 h). Several genes found to be rel-
evant to neuronal cell death were differentially expressed in
the RGC-5 cells. These included: mitogen activated protein
kinase 8 interacting protein (MAPK8IP) 1.9- fold and death-
associated protein 1 (DAP-1, RAP7A), 1.9 fold at 8 h; pro-
grammed cell death 4 (PDCD4), 2.3 fold and MAPK8IP (2.8-
fold) at 24 h; GTP cyclohydrolase 1 (Gch) 2.6 fold and growth
arrest and DNA-damage-inducible 45 (Gadd45) 3 fold at 48
h; Gadd45 (4.7 fold) and deoxyribonuclease (DNase-1; 18.9
fold) at 96 h. After exclusion of the 8 h time point, the data
indicated other differentially expressed genes common to the
24, 48, and 96 h time points and included the 5 known neu-
ronal cell death genes: Cyr61, TGFβ, Bok, Bnip3l, and DNase-
1. Together, these results indicated that the initiation of
apoptosis pathways in RGC-5 cells involved a number of
known cell death genes.
Comparative data analyses:  Before comparing the pat-
terns of expression in RGC-5 cells with data from other pub-
lished databases, we compared our results with a rat retina
cDNA EST screening library [18]. In the latter study, the iden-
tified clones were obtained from the EST library and linked to
human optic neuropathies. We found 44 of the 72 genes iden-
tified by Farkas et al. [18] to be specific to the rat (Rattus
norvegicus). Of the other 28 genes, 26 were specific to the
mouse (Mus musculus), and two were specifically human
(Homo sapiens). Twenty-two of the 44 rat genes had altered
expression values in our microarray analysis (Table 3). Of the
22 genes that were not present, we determined that most of
those genes had accession numbers that conflicted with the
accession numbers for genes present in the Agilent microarray.
We also compared the RGC-5 dataset with a study [32] in
which a microarray analysis of the rat retina was used to de-
termine the pattern of gene expression related to elevated IOP.
The data derived from examination of the 96 h time point for
serum-deprived RGC-5 cells were compared with the pub-
lished data derived from rat eyes after 35 days of elevated IOP
(Table 4). Of the 29 genes with RefSeq accession numbers
considered by both studies, 14 genes (Lcn2, Cd74, C3, Lgals3,
C1s, Fcgr3, Arpc1b, Mmp3, Bzrp, Cebpd, Mgp, Cp, Ptpn1,
and Cntf) showed similar changes in gene expression. This
comparison served to illustrate that a number of altered genes
were found in common, although there also appeared to be
novel genes identified in each of the experimental paradigms.
The latter fact is not surprising because the in vivo studies of
the retina represent changes that could have occurred in one
or more of the multiple cell types.
Identification of signaling pathways:  To identify poten-
tial signaling and pathways and gene-regulatory networks that
are associated with retinal ganglion cell death,we imported
the microarray expression data to PathwayAssist (Iobion,
Informatics, LLC). Biological pathways were identified us-
ing genes differentially expressed at: (1) 8, 24, 48, and 96 h,
and (2) 24, 48, and 96 h serum deprivation. Only the genes
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TABLE 3. GENES IDENTIFIED IN OUR MICROARRAY DATA AND OTHER
Comparison between genes identified in our microarray data and
another study reported by Farkas et al. (2004).
TABLE 4. GENES IDENTIFIED IN OUR MICROARRAY AND COMPARED
WITH OTHER DATA
List of differentially expressed genes obtained from our microarray
compared with other data reported by Ahmed et al. (2004). The genes
show similar fold changes between our study and other study are
labeled by asterisk [32]. The selected genes were chosen to be 1.5-
fold change or more.
299containing RefSeq accession numbers were used for this study
because these genes are well annotated and less redundant
compared to other databases. The data (Figure 3) showed the
signaling pathways for the genes that were differentially ex-
pressed and common to the 8, 24, 48, and 96 h time points. Of
the seven annotated genes, only five of them (Cyr61, TGFβ,
Bok, Bnip3l, and DNase 1) were identified in 8, 24, 48, and
96 h. The objective of this experiment was to find other candi-
date genes in gene-regulatory networks. We found 13 candi-
date genes associated with the five genes identified by the
microarray analysis using PathwayAssist. The total of identi-
fied 18 genes led to the further identification of three cellular
processes which included cell survival, apoptosis, and DNA
fragmentation. Two genes (Uxs1, and ATPIF1) were found
not to be connected to any other genes in this pathway.
After removal of the 8 h time point as described, 15 sig-
nificantly down-regulated genes were found to be common to
the 24, 48, and 96 h time points, and these were used to build
a second signaling pathway (Figure 4A). Twelve (Col1a2,
Hsp60, Pfn2, Hmgic, Cyr61, Tgfb2, Sgk,Ywhae, Bok, Cqp5,
Csnk1d, Kcnj1) of these could be used to construct a pathway,
which included 49 additional target genes. A total of 61 genes
were found to be associated with five cellular processes which
included DNA fragmentation, apoptosis, cell death, prolifera-
tion, and cell survival.
In addition, there were 24 significantly upregulated genes
at the 24, 48, and 96 h time points, and there were four cell
processes identified in PathwayAssist (apoptosis, cell death,
cell survival, proliferation, and differentiation). We were able
to use 17 (Cyp2a3a, Sgne1, Dnase1, Rgc32, Gch, Sgne1, Dia1,
H1f0, Scya5, Flot2, Polr2g, Bnip3l, Ggh, Acadm, Uncl19,
Cebpd, Rgs2, Neu1, C3) of these 24 genes to construct a path-
way with an associated 81 additional target genes (Figure 4B).
These 98 total genes were related to cellular processes, which
included DNA fragmentation, apoptosis, cell survival, and
proliferation. Thus, we have identified a series of interacting
genes that constitute a potentially important gene-regulatory
network related to cell death and survival pathways.
Five differentially expressed genes were also imported
into Pathway Assit software (Figure 5). These had been previ-
ously reported to be specifically associated with neuronal cell
death and to have altered expressions following serum depri-
vation for 24, 48, and 96 h. All five differentially expressed
genes seemed to be associated with cell death. The genes in-
volved in DNA fragmentation were Bok and DNase 1 in addi-
tion to their association with death. The results indicated that
these neuronal cell death genes were associated with three cell
processes that included DNA fragmentation, death, and
apoptosis. All these neuronal cell death genes were associated
with apoptosis and they were also related to other target genes
in the cell death pathway. There are three candidate genes re-
ported to be connected to this pathway, which are Bcl2, Bcl2l,
and casp3. We suggest that the limited number of genes in-
volved in neuronal cell death that showed expression changes
after serum deprivation may have been due to the limited num-
bers of annotated genes in the rat genome and the restricted
conditions for data analysis. A stringent p-value had been used
in these analyses.
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Figure 3. Schematic representations
of potential signaling pathways in-
volved in serum-deprived retinal
ganglion cell-5 cells.  Pathways
were identified by incorporating the
microarray results (differentially
expressed genes identified at 8, 24,
48, and 96 h of serum deprivation)
into PathwayAssist software. The
pathway connects the proteins (blue
color) and cell processes together.
Three major biological processes of
cell survival, apoptosis, and DNA
fragmentation, regulated by these
genes are represented by yellow
color squares.
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Figure 4. The biological path-
way of the differentially ex-
pressed genes at 24, 48, and 96
h serum deprivation.  A: Genes
downregulated by serum dep-
rivation (blue color). B: Genes
upregulated by serum depriva-
tion (violet color). The path-
way was constructed on
PathwayAssist software by
searching for the shortest path
to connect the genes of inter-
est by other genes or cell pro-
cesses with which they inter-
acted through expression or
regulation only. Each of these
additional nodes has docu-
mented relation to apoptosis.
The genes highlighted in blue
color are the genes identified
by microarray analysis, and the
genes in red ovals diamonds
color are the potential target
genes identified with the aid of
PathwayAssist.
301Annotation:  To better understand the biological signifi-
cance of these data, 39 differentially expressed genes at the
24, 48 and 96 h time points were annotated with the aid of
software from the Gene Ontology Consortium (eGO Version
1.0). The data presented here (Appendix 1) show the GO an-
notations for the 39 differentially expressed RefSeq genes were
common to the last three time points. The GO tool [39] has
annotated genes in several model organisms that comprise three
related hierarchies, including molecular functions, biological
processes and cellular locations. For example, six of the 39
genes are located on the same chromosome (7q): [H1 histone
family, member (NM_012578); Aquaporin 5 (NM_012779);
calcium channel, voltage-dependent, beta 3 subunit
(NM_012828); high mobility group AT-hook 2 (NM_032070);
lectin, galactoside-binding, soluble 2 (NM_133599); and
NADH-cytochrome b5 reductase (NM_138877)]. However the
subcellular localization and functions of the gene products are
quite different (Appendix 1). Mapping genes to the GO data-
base is a useful tool for the automated extraction of useful
biological information from gene expression data.
Validation of microarray data:  Real-time RT-PCR as-
says were performed for 14 genes whose expression levels
were either upregulated or downregulated at the 24, 48, and
96 h time points (Figure 6). The genes include Ftl1, C3, C1s,
Neu1, Polr2g, Acadm, Nupr1, Gch, Dia1, DNase1, Tgfb2,
Cyr61, Cyp2a3a, and Lagls2. The expression of all genes was
normalized to the 18S ribosomal RNA (housekeeping gene).
Our real-time analysis of the 18S gene expression revealed
that it was unaffected by serum deprivation since the differ-
ence in CT values between apoptotic and nonapoptotic samples
were negligible, which justified the use of 18S for normaliza-
tion. There was an absence of RT-PCR product in samples in
which the reverse-transcription step was omitted, which indi-
cated that the results obtained represented true amplification
of mRNA molecules. Overall, the gene expression trends by
real-time RT-PCR concurred with the microarray data for all
genes except a few, although the magnitude of changes dif-
fered (the only discordant genes were Cyp2a3a, Lagls2). The
differences in relative expression by these two techniques may
be attributed to their differences in kinetics and sensitivity. In
general, relative expression changes by microarray analysis
were greater than those by real-time RT-PCR, especially for
genes that were markedly over-expressed. This may be ex-
plained by the better sensitivity, and perhaps, the better reli-
ability, of microarray compared to the real-time RT-PCR
method. RT-PCR was performed in parallel for genes differ-
entially expressed at each time point to confirm or support the
detected changes of expression levels. If the gene expression
ratio is higher than 1, it is considered upregulated and if it is
lower than 1, it is considered downregulated.
The data gathered from our microarray data and real time
RT-PCR results indicated that C3 is significantly upregulated
in RGC-5 serum deprivation. A recent study indicated that
factor H inhibits the alternative pathway of complement acti-
vation, and a critical regulator of C3 activation in vivo, as
well as factor H-deficient mice (Cfh-/-) mice spontaneously
develop membranoproliferative glomerulonephritis (MPGN)
that depends on C3 activation [40]. The data from this study
showed that complement factor H (CFH) expression value
were down-regulated about 0.6 fold in 48 h and 0.69 fold in
96 h during RGC-5 serum deprivation. Therefore, CFH was
further investigated in RGC-5 and adult rat retina.
Confocal microscopy:  To examine the expression pat-
tern of CFH in RGC-5 cells and rat retina, we used antibody
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Figure 5. Biological pathway for the
differentially expressed neuronal
cell death genes in serum-deprived
retinal ganglion cells.  Pathways
were identified by incorporating the
microarray results (genes which are
differentially expressed at 24, 48,
and 96 h) into the Pathway Assit
software. The pathway was con-
structed on this software by search-
ing for the shortest path to connect
the genes of interest by other genes
or cell processes with which they
interacted through expression or
regulation only. Three major bio-
logic processes are identified
(apoptosis, death, and DNA frag-
mentation) and are represented by
yellow rectangles. Blue ovals denote
genes identified as neuronal cell
death, and red ovals new genes con-
nected to this pathway.
302to CFH. The RGC-5 cells (Figure 7C) showed intense factor
H immunoreactivity in the cytosol with no reactivity in the
nucleus. Merged images of factor H and Hoechst nuclear stain
immunofluorescence clearly showed that factor H was ex-
pressed in the cytosol of the transformed RGC-5 cells (Figure
7D). As expected, there was no positive immunoreactivity with
goat IgG controls (data not shown). For the adult rat retina,
the immunofluorescence labeling of factor H in the retina (Fig-
ure 8) was observed predominantly in the RGC layer (white
arrows in Figure 8C) and nerve fiber layer (fluorescent green
arrow in Figure 8C) with positive immunolabeling in the pho-
toreceptor cells (blue arrow in Figure 8C), RPE (light blue
arrow in Figure 8C), choroids (red arrow in Figure 8C), and
inner plexiform layer (purple arrow in Figure 8C). A diffuse
labeling was observed throughout the thickness of the retina.
The differential interference contrast (DIC) image of the retina
is shown in Figure 8A. The retina was also stained with Hoechst
nuclear stain (Figure 8B), and the merged image for factor H
and Hoechst nuclear stain is shown in (Figure 8D). As ex-
pected, there was no positive immunoreactivity in IgG con-
trol retinas (data not shown).
DISCUSSION
 Previous studies have suggested that serum deprivation in-
duces apoptosis of RGC-5 cells through activation of mito-
chondrial signaling pathways [23]. The percentages of dying
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Figure 6. Comparative evaluation of microarray and real-time RT-PCR results.  Twelve genes, identified as differentially expressed in gene
arrays and regulated in response to time-dependent serum deprivation, were evaluated with RT-PCR. Values on the y-axis represent the fold
change derived from the mean expression value for each gene, and values on the x-axis represent the time course of RGC-5 serum deprivation.
Total RNA isolated from these cells was used for both microarray analysis and real-time RT-PCR. The closed circles (rectangle) represent
microarray results, whereas the closed squares (circle) represent the quantitative RT-PCR data.
303cells in serum-deprived media were shown here to be 9% at 8
h, 20% at 24 h, 48% at 48 h, and 85% at 96 h, and serum
deprivation resulted in the upregulation of the pro-apoptotic
Bax (NM_0.017059) and the downregulation of the anti-
apoptotic BcL-2 (NM_016993). These data are consistent with
our previously published [23] findings. The aforementioned
studies were further extended here through use of gene
microarrays, which allow for the simultaneous analysis of thou-
sands of transcripts. This approach provides a larger view of
the gene-regulatory networks involved in this particular model
of retinal cell death.
Previously, most microarray studies have used a two-point
system in which changes in expression between two different
(control and experimental) states were compared, however, in
this study, we used multiple time points. This approach led to
the identification of some genes (Table 1) that were common
to all time points, thereby enhancing their likely biological
significance, and these are the primary focus of this report.
There were many genes (Table 2) which were changed rela-
tive to a single time point. The presence of such changes may
be indicative of the different phases of cell death as well as
the activation of other cellular processes. These latter find-
ings have not been extensively addressed in this report.
Ahmed et al. [32] recently reported that the complement
component, C3, was upregulated after elevation of IOP in the
rat eye by 8.5 fold at eight days and 10.5 fold at 35 days.
Furthermore, several immune response genes were shown to
be upregulated in monkeys with glaucomatous eyes [41]: C3
(1.9 fold), C3r (1.9 fold), and C1q (1.9 fold). Therefore, it was
particularly noteworthy to see that the complement system was
also activated in serum-deprived RGC-5 cells. A subset of dif-
ferentially expressed genes identified in microarray data was
validated using QRT-PCR (Figure 6). The present studies
showed that the complement component, C3, is consistently
up-regulated in serum-deprived cells by 6.5 fold at 24 h, 7.3
fold at 48 h, and 31.6 fold at 96 h. This dramatic increase in
C3 was validated with RT-PCR (Figure 6). The complement
components have been implicated in several brain disorders,
especially where neurodegeneration is evident. For example,
elevations in C3 mRNA expression have been demonstrated
in patients with Alzheimer’s disease [42-44]. Recent studies
have suggested that the complement system either directly or
indirectly contributed to cell death [45]. In addition to C3, the
C1s (NM_138900) subcomponent of complement was con-
sistently upregulated by 2.2 fold (24 h), 2.9 fold (48 h), and
9.6 fold (96 h) in serum-deprived RGC-5 cells. This subcom-
ponent is responsible for cleavage of C4 and C2, which then
triggers activation of the classical pathway [46]. The elevated
levels of several complement components shown here indi-
cate that RGC-5 cells are capable of synthesizing these com-
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Figure 7. Confocal immunocy-
tochemical localization of comple-
ment factor H (CFH) in RGC-5.
The DIC image is shown in (A) and
the nuclear staining by Hoechst stain
is shown in (B). Arrows in A and B
depict the cells and the nuclei of the
RGC-5 cells, respectively. Comple-
ment factor H (CFH) in green (ar-
rows in C). The merged images of
these RGC-5 cells are shown in D
(arrows). CFH was expressed in the
cytoplasm (arrows in B and D).
304ponents. Future studies should examine this possibility in the
RGCs in animal models, and in the eyes of patients who have
blinding diseases, because this would open a new door to the
development of treatments for such diseases. While the retina,
and the nervous system as a whole, has traditionally been seen
as separate from the immune system, there has been increas-
ing evidence over the last decade or two that glia mediate the
immune functions of the nervous tissues. It now seems pos-
sible that neurons also have their own innate capacity for im-
mune functions [47].
The present study indicates a decrease in the levels of
survival promoting genes such as Akt. There were three mem-
bers of the Akt gene family that were affected in the present
studies: Akt1 (NM_033230); Akt2 (NM_017093); and Akt3
(NM_031575). They were down-regulated in RGC-5 cells after
96 h serum-deprivation by 0.69 fold, 0.55 fold, and 0.54 fold,
respectively. The downregulation of Akt1, observed in all se-
rum-deprived RGC-5 samples is consistent with results ob-
tained by Miyahara et al [41] in which Akt1 was downregulated
in monkeys with mild and severe glaucomatous retinas. Akt
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Figure 8. Confocal immunocytochemical localization of complement factor H complement factor H in the adult rat retina.  A DIC image of
retina showing various layers of rat retina (A). The nuclear staining by Hoechst stain is shown in (B). Intense factor H immunolabeling (C)
was detected in retinal ganglion cell (RGC) layer (white arrow) including the nerve fiber layer (fluorescent blue arrow). Factor H labeling was
also detected in the inner plexiform layer (purple arrow), photoreceptors (blue arrow), and the choroids (red arrow). The merged image of B
and C is shown in D. INL indicates inner nuclear layer; ONL indicates outer nuclear layer; RPE indicates retinal pigment epithelium layer; and
CH indicates choroids.
305may participate in constitutive survival processes in retinal
neurons [48]. The Akt genes shown here, Akt1, [49] Akt2, [50]
and Akt3, [51] are located on chromosomes 14q32, 19q13,
and 1q44, respectively. All are widely, but differentially, ex-
pressed in various tissues. Members of the Akt family are im-
portant mediators of cell survival and have been shown to sup-
press the apoptotic death of a number of cell types induced by
a variety of stimuli, including growth factor withdrawal [52-
55]. Thus, Akt may promote cell survival through inhibition
of a component of the cell death machinery [54].
Serum-glucocorticoid kinase (SGK) is downregulated at
three time points (24, 48, and 96 h) of serum deprivation (Table
2). SGK, a 49-kDa serine/threonine kinase shares consider-
able structural similarity with Akt [56,57]. Akt-1 and SGK-1
are homologous kinases that are important downstream effec-
tors of PI3-K signaling [58]. The PI3-K/Akt signaling plays a
critical role in mediating survival signals in a wide range of
neuronal cell types. These cells die through an apoptotic pro-
cess after withdrawal of trophic factor [59]. In this regard, we
do know that the use of blocking antibodies for BDNF and
TrkB receptors leads to RGC-5 cell death [60].
The PI3-K pathway activation provides a strong protec-
tive effect through sustained activation of the downstream in-
termediary Akt, and the protective effect of Akt activation is
mediated primarily through phosphorylation of BAD [61]. Our
results showed that the expression of BAD, a pro-apoptotic
member of the Bcl2 family increased 2.0 fold at 24 h and 2.2
fold at 96 h in serum-deprived conditions, a finding that is
compatible with the decreased of Akt expression.
In this study, the upregulation of complement proteins
and the downregulation of Akt suggested that these two sys-
tems may be interrelated. Rus et al. [62] reported that cell sur-
vival enhanced by C5b-9 is mediated by the PI3-kinase/Akt
pathway, which inhibits apoptosis through regulation of BAD.
Schematic signal transduction pathways involved in cell pro-
liferation and survival induced by C5b-9 mediated through
RAS, P13-K, Akt and BAD pathways has been previously
reported [62].
It has been reported that CFH gene, an important regula-
tor of the alternative complement cascade, is associated with
age-related macular degeneration (AMD) [63]. Since Cfh is
the main regulator of C3 activation [40]. Here we report that
the Cfh (NM_130409) expression was significantly
downregulated at 48 h 0.60 fold (p-value of 0.0077) and 96 h
0.69 fold (p-value 0.0279) in serum-deprived samples. Con-
focal microscopy studies reveal that complement factor H im-
munoreactivity was present in RGC-5 (in the cytosol), while
in the rat retina, it was observed in the RGC layer and nerve
fiber layer.
Neurons have the capability to express the mRNAs of
complement proteins in vivo [42,47]. Complement proteins
have been implicated in several brain disorders including
neurodegenerative diseases, [47] such as in the brain with
Creutzfeldt-Jakob disease, [64] and in Alzheimer’s disease
[43,44]. CFH, the major inhibitor of the alternative comple-
ment pathway, was a constituent of retinal lesions (drusen) in
human donors with a history of AMD [63]. Complement pro-
tein plays an important role in immuno-regulation and may
also exert pro- or anti-apoptotic effects in various cell types
[65]. The complements system is receiving increasing atten-
tion as it becomes more important in the pathogenesis of tis-
sue injury following immune, ischemic, or infectious insults
[66]. Abnormalities, of Cfh have been implicated in MPGN in
both human and experimental animal models [43]. Mice defi-
cient in factor H (Cfh-/- mice) developed MPGN spontaneously
and were hypersensitive to developing renal injury caused by
immune complexes [40].
In conclusion, we showed the use of immortalized RGC-
5 cells to study a high-throughput genome-wide gene expres-
sion profile for serum-deprived cells. We propose that the pat-
terns of expression reflect the withdrawal of trophic factors
associated with the serum. This approach is more suitable to
contribute to a realistic view of the complex series of events
that terminate in cell death than looking solely at the effects
of individual genes. We believe that the differentially expressed
genes identified in both microarray and real-time RT-PCR tech-
niques most likely play an important role in RGC-5 cell death
due to serum deprivation. These data implicate a role for in-
creased expression of complement components and a reduced
expression of complement factor H and Akt in RGC-5 cell
death.
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